SEC Filing Details

Our enduring purpose: To fundamentally improve the lives of patients with serious diseases in ways never before possible

SEC Filing Details

Document Details

Form
Filing Date
Apr 4, 2019
Document Date
May 15, 2018
Form Description
Amendment to a previously filed 4
Filing Group
3,4,5
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS INC
Filer
Irving Bryan